Merck

Cardiome gets boost from Merck

Globe and Mail (Free subscription) | yesterday

Deferred revenue payments from partnership help Cardiome trim loss

NATAP: pharmatimes reports merck/schering merger (2050)

aids-write.org (Free subscription) | yesterday

Larger Merck says merger will actually increase R&D efficiency pharmatimes.com 05 November 2009 The new Merck & Co has opened its doors for business, and the company has been laying out its plans for future growth now that Schering-Plough has been added to the group. Chief executive Richard Clark says that “our integration teams prepared us [...]

Merck operates in 140 countries including the Philippines

Positive News Media (Free subscription) | 08/11/2009

MANILA, Nov. 9 (PNA) -- Merck & Co., Inc. has outlined its global strategy following the completion of Merck's merger with Schering-Plough Corporation.

Pre-Market Stock Upgrades/Downgrades Nov 9, 2009

Wall Street Pit (Free subscription) | yesterday

Here is a list of this morning’s company upgrades, downgrades, and coverage initiations by Wall Street brokerage firms. Analyst Upgrades: Merck (MRK) upgraded to Outperform at Leerink Swann Credit Suisse raises its price target on Hewlett-Packard (HPQ) to $60 from $55 FBR Capital raises its...

Know Your Limits: Government Lawyers Weigh In...

Jim Hamilton’s World of Securities (Free subscription) | 5 hours ago

Know Your Limits: Government Lawyers Weigh In on Inquiry Notice Case In late November the U.S. Supreme Court will hear oral argument in an important securities litigation case. The court will address the meaning of "inquiry notice" for limitations purposes in its review of Merck & Co. v. Reynolds , a 3rd Circuit decision arising from the Vioxx litigation. The U.S. District Court for...

19 High Yield Stocks that Historically Outperform

SeekingAlpha.com (Free subscription) | yesterday

Scott's Investments submits: In early October I detailed 2 high yield investment strategies ( part 1 and 2 ) that have had a history of outperformance. Below is the list of stocks meeting the two strategies criteria as of the close on November 6th. Obviously, past performance does not mean these strategies will continue to outperform in the future. However, a variety of momentum strategies (part 1)...

Generics Gateway

Indian Express (Free subscription) | yesterday

If generics are the gateway of growth for global pharmaceutical giants such as AstraZeneca, Pfizer, Sanofi-Aventis, Novartis, Merck and GlaxoSmithKline, there is a clear and renewed thrust on the $17 billion Indian pharmaceutical market.

Marcia G. Yerman: The Gardasil Vaccine Series - An Interview with Merck & Co., Inc.

The Huffington Post (Free subscription) | 06/11/2009

Merck is the developer of the HPV vaccine Gardasil. The company has an independent website, gardasil.com, devoted to explaining the product, complete with social marketing...

Cramer’s 2 Takeover Targets: DNDN & ONXX

Madd Money (Free subscription) | 06/11/2009

Jim Cramer continued on his cancer theme Thursday by recommending two companies that he thinks could be the next big acquisition targets for Big Pharma. “Both Bristol Myers Squibb Co. (NYSE:BMY) and Merck & Co. Inc. (NYSE:MRK) are on the hunt for acquisitions,” Cramer said, “and Dendreon (NASDAQ:DNDN) and Onyx Pharmaceuticals (ONXX) make great targets.” [...]

DotW: Sesame Street

The IN VIVO Blog (Free subscription) | 06/11/2009

In case you failed to run a Google search this week, you may not have realized that on Tuesday Nov. 10, Sesame Street turns 40 . You gotta admit, the show doesn't look a day over five--and that's without Botox. If you've forgotten how to get to Sesame Street , we have a few reminders--and ear worms -- appropriately tailored for the biopharma industry--hey, it's our version of personalized medicine...

Why The Market Is Rising

Capital Observer (Free subscription) | 06/11/2009

Charles Biderman, founder of Trim Tabs, has done extensive studies on liquidity. When a company is bought out in a cash takeover, investors holding the shares are likely to take the cash they receive and buy other stock. His models show that half of the cash infusion is realized the week the deal is announced as arbs buy stock from shareholders. The other half is realized the week of closing. In the...

Thoughts on What Used to Be Schering-Plough

In the Pipeline (Free subscription) | 06/11/2009

So what are we up to now, Day Three of Greater Merck? The merger with Schering-Plough went through earlier this week, and you won't get any more numbers by searching the stock tickers for SGP. I find that weird, since I started my career there in the late 1980s/early 1990s. But while I was there, it seemed like there were mergers and rumors of mergers every few weeks. That's no doubt a hindsight-enhanced...

Merck - Saphris: now here's something you don't read in an FDA document every day

PharmaGossip (Free subscription) | 06/11/2009

iChemoTracker Keeps Tabs on Your Chemo Regiment

Medgadget (Free subscription) | 06/11/2009

Merck has released the iChemoDiary for the iPhone platform, an app designed to help patients monitor their time on chemotherapy. The software allows patient to compile chemo treatments, side effects, and general well being, through a set of criteria, that can be later presented to a healthcare provider. Track your chemotherapy schedule, medication, and treatment plan Record some of the possible side...

StockSource.us Reports MNDP Expands Reach Internationally

Radon Mitigation Pittsburgh (Free subscription) | 06/11/2009

( EMAILWIRE.COM , November 05, 2009 ) Del Mar, CA - Mundus Group, Inc. through subsidiary AirStar International, continue to soar from strength to strength with their pioneering technologies. With over 20 years in the design and development of their patented VTOL UAV (Vertical Take Off and Landing; Unmanned Air Vehicle) technology, they are able to cater to diverse markets while expanding their reach...

• StockSource.us Reports MNDP Expands Reach Internationally - EmailWire.Com